Enzymatic inhibitor is a kind of drug for the treatment of AIDS virus infection.
This drug can bind to certain functional groups on the active center of the protease molecule, reducing or even disappearing the activity of the protease, but it cannot denature the enzyme protein. In the treatment of HIV-1 infection, the use of protease inhibitors can inhibit virus replication and have a certain effect on disease control. AIDS is a highly contagious infectious disease. AIDS is caused by HIV infection. This virus can attack the human immune system, making people lose immunity, and patients will eventually die of various complications. There is no specific drug to treat AIDS, but the replication of the virus can be controlled through drugs. At present, the commonly used drug for the treatment of AIDS is protease inhibitor, which can inhibit the activity of protease, and the common drugs are nefenavir, saquinavir, indomethacin, etc. Therefore, the mechanism of action of inhibiting protein body inhibitors. In the process of encoding human immunodeficiency virus genes, an important protease is needed. It belongs to a special type of aspartic protease, which can break down the protein expressed by the gene into the active structure of the virus, which is a key substance for HIV replication. Protease inhibitors such as nefenavir, saquinavir, and tidenavir are relatively effective anti AIDS drugs, which can effectively control the replication of the virus. Inhibiting adverse reactions of protein body inhibitors. Previous studies have shown that patients who take protease inhibitors may experience abnormal fat deposition, such as the back of a water buffalo, full moon face, and ampulla, all of which are manifestations of fat accumulation in different parts of the body. However, some patients may experience fat consumption after taking medication, mainly occurring in the limbs and face. In the treatment of AIDS virus infection, proteasome inhibitors are usually used. There are many kinds of drugs that can inhibit the replication of the virus in the body and control the occurrence of disease. The application prospects of protease inhibitors still need to be observed, and this drug generally needs to be used in combination with other drugs.
